CNRS-Université de Bordeaux
4 months ago
Fully Funded PhD in Iridium Organometallic Chemistry for Photodynamic Therapy CNRS – Université de Toulouse in France
Degree Level
PhD
Field of study
Chemistry
Funding
Fully funded 36-month doctoral contract / 36-month doctoral contract. The thesis starts on 01/10/2026 (October 1, 2026).
Deadline
Oct 1, 2026
Country
France
University
CNRS-Université de Bordeaux

How do I apply for this?
Sign in for free to reveal details, requirements, and source links.
More information can be found here
Keywords
Suggested positions
About this position
Fully funded PhD opportunity in iridium organometallic chemistry for photodynamic therapy at CNRS – Université de Toulouse, hosted in the Laboratoire de Chimie de Coordination (LCC) within the Medicinal Chemistry & Biology for Oncology team.
The project focuses on the synthesis, characterization, and biological evaluation of iridium complexes designed as photosensitizers for cancer-related phototherapy. Research topics include N-heterocyclic carbenes, organometallic synthesis, structural characterization, photophysical measurements, ROS production, and biological assays. The work sits at the chemistry–biology interface and has relevance for oncology, antibacterial, and antiparasitic applications.
Supervisors: Céline Deraeve and Heinz Gornitzka.
Funding: 36-month doctoral contract, fully funded. The thesis is scheduled to start on 2026-10-01.
Eligibility highlights: Master’s degree in Organic Chemistry, Medicinal Chemistry, Organometallic Chemistry, or a related field; strong experience in organic synthesis; good knowledge of analytical techniques such as NMR, MS, and chromatography; interest in biomedical applications and interdisciplinary research.
How to apply: Prepare a detailed CV, cover letter, reference contacts, and transcripts (M1 or equivalent; M2 if available). Submit the application to the supervisors using the contact emails provided in the post.
Funding details
Fully funded 36-month doctoral contract / 36-month doctoral contract. The thesis starts on 01/10/2026 (October 1, 2026).
What's required
Master’s degree in Organic Chemistry, Medicinal Chemistry, Organometallic Chemistry, or a related field. Strong experience in organic synthesis is required, along with good knowledge of analytical techniques such as NMR, MS, and chromatography. The candidate should be interested in the chemistry-biology interface and biomedical applications, motivated by cancer research and phototherapy approaches, and able to work with curiosity, rigor, and in an interdisciplinary team. Solid background in standard analytical techniques is preferred.
How to apply
Send a detailed CV, cover letter, contact information for references, and transcripts (M1 or equivalent; M2 if available).
Ask ApplyKite AI

How do I apply for this?
Sign in for free to reveal details, requirements, and source links.